-

Bed Bath & Beyond Corporation Investor Notice: Robbins LLP is Investigating Bed Bath & Beyond Corporation (BBBY) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Bed Bath & Beyond Corporation (NASDAQ: BBBY) and its officers and directors to determine if they breached fiduciary duties or violated securities laws in connection with the aggressive pump and dump scheme initiated by insiders. BBBY operates a nationwide chain of retail stores.

If you would like more information about our investigation of Bed Bath & Beyond Corporation's misconduct, click here.

What is this Case About: According to the complaint filed against BBBY, insiders manipulated the Company to enable an aggressive pump and dump scheme that harmed shareholders. Specifically, defendant Ryan Cohen has a history of employing pump and dump schemes to ignite meme stocks to jaw-dropping heights. In March 2022, Cohen's corporation, RC Ventures LLC, bought a nearly 10% stake in BBBY. Thereafter, BBBY gave Cohen three board seats. For four months, BBBY stock climbed from its lowest price of $4.38 per share on July 1, 2022, to $30.00 per share on August 17, 2022.

On August 16, 2022, Cohen filed a Schedule 13D with the SEC indicating he beneficially owned 9,450,100 shares – approximately 11.8% of the shares outstanding – of BBBY. However, the Schedule 13D filing was materially false and constitutes a false written filing because Cohen sold most of the 9,450,100 shares when the filing was submitted and intended to create a buying frenzy of BBBY stocks so he could finish selling his shares at an artificially inflated price. Cohen also filed Form 144 on paper providing notice of his intent to sell up to all his shares and additional call options. This filing was not disclosed to the public until the market closed the next day, August 17, 2022, at 5:07 pm, when Cohen finished dumping his BBBY shares. Right after the disclosure of the filing, BBBY shares tumbled after hours from a record high $30.00 per share to around $22.5 per share.

On August 18, 2022, Cohen reported he had sold all his shares as of August 16, 2022. On this news, BBBY sock fell 45%. Over the next several days, the stock fell from its August 17 high to close at $8.78 per share on August 23, 2022. The Company lost more than $800 million in market capitalization while insiders profited at least $110 million from their sales on August 16 & 17.

Next Steps: If you acquired shares of Bed Bath & Beyond Corporation between March 25, 2022 and August 18, 2022, you have legal options. Contact Robbins LLP for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Bed Bath & Beyond Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:BBBY

Release Summary
Bed Bath & Beyond Corporation insiders allegedly engaged in aggressive pump and dump scheme to the detriment of shareholders
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call...

ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities between August 9, 2024 and March 25, 2026. ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. For more information...

VIA Transportation, Inc. Stock Drop: Harmed Investors Should Contact Robbins LLP for Information About Leading the Class Action Against VIA

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Via Transportation, Inc. (NYSE: VIA) in connection with the Company's September 15, 2025 initial public statement ("IPO"). Via Transportation, Inc. provides a platform that transforms global transportation systems into digital networks in the United States, Germany, and internationally.For more information, submit a form, email attorney Aaron D...
Back to Newsroom